InVivoMAb anti-mouse CD45.2 BE0300-R025mg from Bio X Cell

Description

Bio X Cell InVivoMAb anti-mouse CD45.2 Monoclonal Antibody has the following reported applications: Flow cytometry, in vivo CD45.2 blockade, in vitro CD45.2 blockade, Immunohistochemistry (frozen). It features greater than 95% purity, ultra-low endotoxin levels, and are preservative, stabilizer, and carrier protein-free

Product Specs
ItemInVivoMAb anti-mouse CD45.2
CompanyBio X Cell
Price Pricing Info Supplier Page View Company Product Page
Catalog NumberBE0300-R025mg
ImmunogenB10.S mouse thymocytes and splenocytes
Antibody TypePrimary Antibody
Purity>95%, Determined by SDS-PAGE
FormatPBS, pH 7.0, Contains no stabilizers or preservatives
Research AreaCancer Biology, Immunology, Innate Immunity
ReactivityMouse (Ms)
ClonalityMonoclonal
NCBI Gene AliasesB220, CD45R, Cd45, L-CA, Ly-5, Lyt-4, T200, loc
NCBI Full Gene Nameprotein tyrosine phosphatase receptor type C
ApplicationsFCM, IHC-fr, BL
Hostmouse
Clone104.2
IsotypeIgG2a, κ
TargetCD45.2
Conjugate/TagUnconjugated
ConcentrationLot specific,typically between 4-11 mg/ml
Quantity25 mg

Specifications/Features

Other available quantities: Available in 1, 5, 10, 25, 50, 100 mg and bulk sizes. Academic discount available.

Endotoxin: <2EU/mg (<0.002EU/µg), Determined by LAL gel clotting assay

Add to Compare List

Bio X Cell

39 Labombard Rd

Lebanon, NH 03766

United States

Phone: 1-866-787-3444

Email: customerservice@bxcell.com

Company Profile

Website: bioxcell.com

(1) Intracellular immune sensing promotes inflammation via gasdermin D-driven release of a lectin alarminNature immunologyFebruary 1, 2021Russo AJ, Vasudevan SO, Méndez-Huergo SP, Kumari P, Menoret A, Duduskar S, Wang C, Pérez Sáez JM, Fettis MM, Li C, et al.

(2) T cells maintain an exhausted phenotype after antigen withdrawal and population reexpansionNature immunologyJune 1, 2013Utzschneider DT, Legat A, Fuertes Marraco SA, Carrié L, Luescher I, Speiser DE, Zehn D.

(3) Gut cryptopatches: direct evidence of extrathymic anatomical sites for intestinal T lymphopoiesisImmunityNovember 1, 2000Suzuki K, Oida T, Hamada H, Hitotsumatsu O, Watanabe M, Hibi T, Yamamoto H, Kubota E, Kaminogawa S, Ishikawa H.

(4) Alleviation of autoimmunity in BXSB mice by monoclonal alloantibody to Ly-5 (CD45)European journal of immunologyAugust 1, 1989Yakura H, Ashida T, Kawabata I, Katagiri M.

(5) Selective inhibition of lipopolysaccharide-induced polyclonal IgG response by monoclonal Ly-5 antibodyJournal of immunology (Baltimore, Md. : 1950)April 15, 1986Yakura H, Kawabata I, Shen FW, Katagiri M.

(6) On the function of Ly-5 in the regulation of antigen-driven B cell differentiation. Comparison and contrast with Lyb-2The Journal of experimental medicineApril 1, 1983Yakura H, Shen FW, Bourcet E, Boyse EA.

Be the First to Write a Review!